The contractor shall provide enhanced analysis of clinical and specimen-derived data on all patients seen at VA network hospitals who have a cancer diagnosis. The contractor shall furnish a robust,…

Ended Indefinite Delivery Contract Awarded Last action

Contract number
VA24114D0176
Awardee
Awarding agency
Task orders
9 $2,107,469 obligated

Award facts

Combined order value
$2,107,469 Current and potential, with all options
Last date to order 100% complete
Maximum order
$650,000.00
Award type
Multiple award
Who can order
Only the awarding agency
Set-aside
Total Small Business
Competition
Competed under SAP · 4 offers Simplified Acquisition
Pricing
Firm Fixed Price
Legislative mandates

Award details come from SAM.gov/FPDS.

Description

The contractor shall provide enhanced analysis of clinical and specimen-derived data on all patients seen at VA network hospitals who have a cancer diagnosis. The contractor shall furnish a robust, scalable, dynamic, secure, innovative solutions of analyzing samples obtained during regular clinical care such as tissues from biopsy - using new genomic assay technology. The clia vendor shall provide emerging technologies to improve oncology care for all patients within the VA healthcare system. The contractor shall provide targeted sequencing of DNA fragments known to harbor mutations in cancer specimens (commonly referred to as a mutation panel). The number of DNA segments sequenced varies by the laboratory and assay performed. Mutations in the DNA can either be inferred against a laboratory `reference sequence or can be determined by sequencing of patient germ-line DNA obtained from adjacent normal tissue or peripheral blood. The contractors shall provide sequencing of the whole exome of cancer specimens, with mutations identified by comparison against a laboratory `reference sequence or germ-line DNA as described above. The contracotr shall provide sequencing of the cancer specimen RNA or `transcriptome . This strategy can be combined with either targeted or whole exome DNA sequencing. Products of the testing returned to the VA include all sequence data including raw test data (fast-Q, BAM, read quality files and variant call files) and a report of important mutations and their significance to be returned to the medical record. Mutations found in the tumor sample will be annotated so that clinicians can gain an understanding of their meaning. The laboratory shall specify how this annotation will be performed and in particular, what knowledge base will be used to generate the annotations. The contractor shall maintains an up-to-date knowledge base and must be able to update annotations of a patient report upon request. The contractor shall at all times maintain a secure environment and practice covering all protected health information (PHI).

Task orders

Task order Ordering agency Obligated Awarded
Genomic analysis of cancerous tumor tissue VA24117J2259 Veterans Integrated Service Network 1 (VHA) $313,025
Genomic analysis of cancerous tumor tissue VA24117J1763 Veterans Integrated Service Network 1 (VHA) $449,600
P00001 accession 64 gene plasmid assay, plasmaselect; modify and supplement distribution of clinical reports and… VA24117J1089 Veterans Integrated Service Network 1 (VHA) $349,600
The contractor shall provide enhanced analysis of clinical and specimen-derived data on all patients seen at VA network… VA24117J0678 Veterans Integrated Service Network 1 (VHA) $147,900
The contractor shall provide enhanced analysis of clinical and specimen-derived data on all patients seen at VA network… VA24116J2218 Veterans Integrated Service Network 1 (VHA) $437,100
The contractor shall provide enhanced analysis of clinical and specimen-derived data on all patients seen at VA network… VA24116J1419 Veterans Integrated Service Network 1 (VHA) $98,925
The contractor shall provide enhanced analysis of clinical and specimen-derived data on all patients seen at VA network… VA24116J1098 Veterans Integrated Service Network 1 (VHA) $72,481
Task order for second ordering period VA24116J0465 Veterans Integrated Service Network 1 (VHA) $49,838
The contractor shall provide enhanced analysis of clinical and specimen-derived data on all patients seen at VA network… VA24114J2145 Veterans Integrated Service Network 1 (VHA) $189,000

Transactions

Action Obligated Date
Supplemental Agreement for work within scope P00001 · Genomic analysis of cancerous tumor tissue $0
Original award $0

Quick answers

Who was awarded contract VA24114D0176?

VA24114D0176 was awarded to Personal Genome Diagnostics Inc. by Veterans Integrated Service Network 1 (Veterans Health Administration) on September 30, 2014.

How much is contract VA24114D0176 worth?

Orders under VA24114D0176 have obligated $2,107,469. A single order can be worth up to $650,000.

How many orders have been placed under contract VA24114D0176?

9 orders have been placed under VA24114D0176, the latest on September 27, 2017.

Who can order from contract VA24114D0176?

VA24114D0176 is a multiple award indefinite delivery contract. Only the awarding agency can place orders on it.

Was contract VA24114D0176 competed?

The extent of competition for VA24114D0176 was competed under sap. The government received 4 offers. It was set aside: Total Small Business.

On GovTribe

See this IDV's full record

  • Every order and transaction
  • The awardee's other awards and teaming partners
  • Similar IDVs and recompete opportunities
  • Ask GovTribe AI about this IDV